Health

Pharmalittle: FDA Review of Moderna’s Flu Shot

Updated 2026-06-18 13:40 UTC 1 source Neutral

The FDA is reviewing Moderna's flu shot while Johnson & Johnson continues to focus on cancer research and avoids the obesity market. The review could impact future vaccine development.

Coverage timeline — 1 article

STAT News

STAT+: Pharmalittle: We’re reading about an FDA review of Moderna’s flu shot, J&J’s focus on cancer, and more

Johnson & Johnson has no plans to enter the booming obesity market, opting instead to focus on diseases such as cancer

2026-06-18 13:28 UTC